Home to world-class discoveries in healthcare, the CU Anschutz Medical Campus is hosting a community lecture series featuring our faculty and research experts examining pressing issues and provocative questions facing the field of medicine.
This Transforming Health Care lecture series, presented by CU Anschutz Chancellor Don Elliman, will feature the top University of Colorado Cancer Center doctors who are working on cutting-edge techniques to diagnose, treat, and prevent cancer in adults and children.
Director of the CU Cancer Center Dr. Richard Schulick will discuss the progress that has been made in cancer research and the promising areas being pursued at the Center. The event will also feature patient stories from devastating diagnoses to receiving life-changing treatments.
As our team continues to push the boundaries of science and medicine, the Transforming Health Care lecture series is a unique opportunity to hear from our doctors on how tomorrow’s cancer breakthroughs are happening today at CU Anschutz.
February 4, 2020 | 5 p.m. - 7:30 p.m.
CU Anschutz Medical Campus, Education 2 South, Room 1102
13121 East 17th Avenue, Aurora, CO, 80045
Dr. Schulick is the Aragon/Gonzalez-Giusti Chair of the Department of Surgery at the University of Colorado School of Medicine. He also serves as the Director of the University of Colorado Cancer Center. Dr. Schulick came to Colorado from the Johns Hopkins Medical Institutions where he was Chief of the Surgical Oncology Division. He is recognized as a leader in the fields of pancreatic, hepatic, and biliary surgery, as well as other areas in cancer surgery. His scientific interests are in the area of tumor immunology. He has pioneered the use of genetically engineered bacteria as well as genetic modifications of cancer cells to treat human cancer. His current laboratory efforts include the discovery of a new immune checkpoint pathway and ways of augmenting immunotherapy.
Dr. Messersmith joined the University of Colorado Cancer Center faculty in 2007 as the Director of Gastrointestinal Medical Oncology and was appointed co-leader of the Developmental Therapeutics Program in 2010 as well as Head of the Division of Medical Oncology in 2014. In 2018, he was appointed Associate Director for Translational Research. Dr. Messersmith leads a division of over 80 faculty and 50 trainees and staff, with basic, translational, and clinical research efforts. He graduated from Harvard Medical School (HMS) in 1998 and trained in internal medicine at Massachusetts General Hospital/HMS. He did his Medical Oncology/Drug Development Fellowship at Johns Hopkins, where he was awarded an ASCO Young Investigator Award and Passano Clinician-Scientist Award. He was on the Hopkins faculty from 2004-2007 as an Assistant Professor in the GI Oncology and Drug Development programs.